IGI Laboratories to Present at 12thAnnual Needham & Company Annual Healthcare Conference on April 30, 2013
BUENA, N.J.--(BUSINESS WIRE)-- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based generic topical pharmaceutical company will be presenting at the 12th Annual Needham & Company's Annual Healthcare Conference. The Conference will take place on April 30 - May 1, 2013 at the Westin Grand Central Hotel in New York, New York.
Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of IGI Laboratories, Inc. will present on Tuesday April 30, 2013, at 4:20 PM ET. Investors attending the conferences who wish to meet with Mr. Grenfell-Gardner and Mrs. Collins for a one-on-one meeting should contact their Needham & Company representative directly.
The replay of the presentation will be webcast and will be available for 90 days online on the Investors section of the Company's website at http://www.igilabs.com.
About IGI Laboratories, Inc.
IGI Laboratories is a generic topical pharmaceutical company. We develop and manufacture topical formulations for the pharmaceutical, OTC, and cosmetic markets. Our mission is to be a leading player in the generic topical prescription drug market.
IGI Laboratories, Inc.
Jenniffer Collins, 856-697-1441
KEYWORDS: United States North America New Jersey
The article IGI Laboratories to Present at 12th Annual Needham & Company Annual Healthcare Conference on April 30, 2013 originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.